Myeloma-Associated Sporadic Late-Onset Nemaline Myopathy, Successfully Treated with Daratumumab Based Induction and Autologous Stem Cell Transplantation: A Case Report. [PDF]
Moriwaki K +5 more
europepmc +1 more source
Treatment response to daratumumab in antibody-mediated kidney allograft rejection: evidence from serial protocol biopsies. [PDF]
Kanzelmeyer NK +7 more
europepmc +1 more source
Low-dose daratumumab and bortezomib for the treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a case report. [PDF]
Zhu J +6 more
europepmc +1 more source
Disseminated varicella-zoster virus infection with gastrointestinal prodromal symptoms during daratumumab therapy for relapsed and refractory multiple myeloma. [PDF]
Horigome Y +9 more
europepmc +1 more source
Efficacy and Safety of Daratumumab-Based Regimens in Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials. [PDF]
Khan AM +9 more
europepmc +1 more source
Targeting CD38 Across Autoimmune and Plasma Cell-Driven Immune-Mediated Diseases: Rationale, Clinical Evidence, and Emerging Therapeutic Landscape. [PDF]
Roccatello D +3 more
europepmc +1 more source
Phase 1/2 trial of Evomela for autologous transplant in myeloma: schedule optimization and matched comparison with MEL200. [PDF]
Bashir Q +24 more
europepmc +1 more source
Mechanistic and Clinical Differences Between Daratumumab and Isatuximab in Multiple Myeloma: Emerging Roles of 1q Gain and Immune Remodeling. [PDF]
Kikuchi J, Yasui H.
europepmc +1 more source

